Hepatitis B (HBV) is a viral infection of the liver and a common cause of chronic liver disease worldwide. An estimated 240 million people are affected by chronic hepatitis B (CHB) infection globally. In the United States, 850,000 to 2.2 million are estimated to be living with HBV. Screening and vaccination efforts have been globally implemented to reduce the burden of disease. This chapter will focus on the diagnosis and management of CHB.
KeywordsChronic liver disease HBsAg Cirrhosis Nucleotide/side analogues Pegylated interferon-alpha
- 3.European Association for the Study of Liver Disease (EASL) 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–98.Google Scholar